280 related articles for article (PubMed ID: 10229835)
1. Requirement for efficient interactions between CD4 and MHC class II molecules for survival of resting CD4+ T lymphocytes in vivo and for activation-induced cell death.
Maroto R; Shen X; König R
J Immunol; 1999 May; 162(10):5973-80. PubMed ID: 10229835
[TBL] [Abstract][Full Text] [Related]
2. Post-thymic selection of peripheral CD4+ T-lymphocytes on class II major histocompatibility antigen-bearing cells.
Shen X; König R
Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):87-96. PubMed ID: 11292263
[TBL] [Abstract][Full Text] [Related]
3. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
4. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
[TBL] [Abstract][Full Text] [Related]
5. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.
Ilkovitch D; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2004 Jun; 53(6):525-32. PubMed ID: 14730400
[TBL] [Abstract][Full Text] [Related]
6. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
[TBL] [Abstract][Full Text] [Related]
7. Alterations in CD4-binding regions of the MHC class II molecule I-Ek do not impede CD4+ T cell development.
Yelon D; Schaefer KL; Berg LJ
J Immunol; 1999 Feb; 162(3):1348-58. PubMed ID: 9973389
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
9. Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cells.
Bot A; Casares S; Bot S; von Boehmer H; Bona C
J Immunol; 1998 May; 160(9):4500-7. PubMed ID: 9574556
[TBL] [Abstract][Full Text] [Related]
10. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
Kleindienst P; Brocker T
Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
[TBL] [Abstract][Full Text] [Related]
11. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor.
Kaye J; Hsu ML; Sauron ME; Jameson SC; Gascoigne NR; Hedrick SM
Nature; 1989 Oct; 341(6244):746-9. PubMed ID: 2571940
[TBL] [Abstract][Full Text] [Related]
12. Selection and function of CD4+ T lymphocytes in transgenic mice expressing mutant MHC class II molecules deficient in their interaction with CD4.
Gilfillan S; Shen X; König R
J Immunol; 1998 Dec; 161(12):6629-37. PubMed ID: 9862691
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC.
Grogg D; Hahn S; Erb P
Eur J Immunol; 1992 Jan; 22(1):267-72. PubMed ID: 1346113
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response.
Pan S; Trejo T; Hansen J; Smart M; David CS
J Immunol; 1998 Sep; 161(6):2925-9. PubMed ID: 9743354
[TBL] [Abstract][Full Text] [Related]
15. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
Sant AJ
J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
[TBL] [Abstract][Full Text] [Related]
16. CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo.
Wang ZQ; Dudhane A; Orlikowsky T; Clarke K; Li X; Darzynkiewicz Z; Hoffmann MK
Eur J Immunol; 1994 Jul; 24(7):1549-52. PubMed ID: 7517874
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
18. Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni.
Hernandez HJ; Wang Y; Tzellas N; Stadecker MJ
Eur J Immunol; 1997 May; 27(5):1170-6. PubMed ID: 9174607
[TBL] [Abstract][Full Text] [Related]
19. Mixed-haplotype MHC class II molecules select functional CD4+ T cells.
Silk JD; Schoendorf D; Bartok I; Chai JG; Gray D; Simpson E; Dyson J
Mol Immunol; 2005 Jun; 42(10):1129-39. PubMed ID: 15829303
[TBL] [Abstract][Full Text] [Related]
20. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
